Fertility and Sterility
Volume 89, Issue 2 , Pages 325-330, February 2008

HOXA10 mutations in congenital absence of uterus and vagina

  • Sasmira Lalwani, M.D.

      Affiliations

    • Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology and Infertility, Tufts-New England Medical Center, Boston, Massachusetts, and Women and Infants Hospital, Providence, Rhode Island
    • Corresponding Author InformationReprint requests: Sasmira Lalwani, M.D., Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology and Infertility, Tufts-New England Medical Center, 750 Washington Street, PO Box 36, Boston, MA 02111 (FAX: 617-636-5906).
  • ,
  • Hsin-hung Wu, M.D.

      Affiliations

    • Department of Obstetrics and Gynecology, Changhua Christian Hospital, Changhua, Taiwan
  • ,
  • Richard H. Reindollar, M.D.

      Affiliations

    • Department of Obstetrics and Gynecology, Mary Hitchcock Hospital, Dartmouth Medical School, Hanover, New Hampshire
  • ,
  • Mark R. Gray, Ph.D.

      Affiliations

    • Department of Anatomy and Cellular Biology, Tufts University School of Medicine, Boston, Massachusetts

Received 25 August 2006; received in revised form 6 March 2007; accepted 7 March 2007. published online 08 May 2007.

Objective

To analyze the HOXA10 genes in CAUV patients for mutations. Congenital absence of the uterus and vagina (CAUV) is the most extreme female reproductive tract developmental defect known. The HOXA10 gene is expressed in the developing and adult uterus. Female mice with loss-of-function Hoxa10 gene mutations have anteriorly directed homeotic transformations of the uterus. Because the HOXA10 gene is expressed in the embryonic paramesonephric (Müllerian) ducts, abnormally low expression by mutant HOXA10 genes might cause CAUV. This hypothesis was tested by analyzing the HOXA10 genes in CAUV patients for mutations.

Design

Case-control study.

Setting

Academic reproductive endocrinology and infertility practice.

Patient(s)

Blood samples were obtained from 26 patients with CAUV and 30 normal controls.

Intervention(s)

DNA samples prepared from blood leukocytes were used as templates for polymerase chain reaction (PCR) amplification of DNA fragments from the HOXA10 gene. The gene fragments were tested for DNA sequence differences using denaturing gradient gel electrophoresis (DGGE).

Main Outcome Measure(s)

To detect DNA sequence differences between patients with CAUV and normal controls.

Result(s)

No DNA sequence differences were found in either patients with CAUV or normal controls in either of the two protein-coding exons of the HOXA10 gene.

Conclusion(s)

Because no HOXA10 gene mutations were found in 26 patients from 25 unrelated families, germ- line mutations in the HOXA10 gene are not a common cause of CAUV.

Key Words: Congenital absence of the uterus and vagina, Mayer-Rokitansky-Küster-Hauser syndrome, HOXA10 gene, Mullerian aplasia

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Presented at the Society for Gynecologic Investigation Annual Meeting, Toronto, Ontario, Canada, March 14–17, 2001, Abstract 390.

PII: S0015-0282(07)00619-X

doi:10.1016/j.fertnstert.2007.03.033

Fertility and Sterility
Volume 89, Issue 2 , Pages 325-330, February 2008